The global Monkeypox Therapeutics market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the Monkeypox Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Monkeypox Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monkeypox Therapeutics. This report contains market size and forecasts of Monkeypox Therapeutics in global, including the following market information:
Global Monkeypox Therapeutics market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five Monkeypox Therapeutics companies in 2024 (%)
Total Market by Segment:
Global Monkeypox Therapeutics market, by Type, 2020-2025, 2026-2032 ($ millions)
Global Monkeypox Therapeutics market segment percentages, by Type, 2024 (%)
Smallpox Vaccine
Antivirals
Vaccinia Immune Globulin (VIG)
Global Monkeypox Therapeutics market, by Application, 2020-2025, 2026-2032 ($ millions)
Global Monkeypox Therapeutics market segment percentages, by Application, 2024 (%)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
Global Monkeypox Therapeutics market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global Monkeypox Therapeutics market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monkeypox Therapeutics revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Monkeypox Therapeutics revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chimerix Inc.
SIGA Technologies, Inc.
Emergent BioSolutions Inc.
Bavarian Nordic A/S
Hetero Drugs Limited
Mylan N.V.
Piramal Enterprises Limited
Olon S.p.A.
Teva Pharmaceutical Industries Limited
CIDIC Company Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Monkeypox Therapeutics, market overview.
Chapter 2: Global Monkeypox Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Monkeypox Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Monkeypox Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Monkeypox Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Monkeypox Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monkeypox Therapeutics Overall Market Size
2.1 Global Monkeypox Therapeutics Market Size: 2024 VS 2032
2.2 Global Monkeypox Therapeutics Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monkeypox Therapeutics Players in Global Market
3.2 Top Global Monkeypox Therapeutics Companies Ranked by Revenue
3.3 Global Monkeypox Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Monkeypox Therapeutics Companies in Global Market, by Revenue in 2024
3.5 Global Companies Monkeypox Therapeutics Product Type
3.6 Tier 1, Tier 2, and Tier 3 Monkeypox Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Monkeypox Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Monkeypox Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Monkeypox Therapeutics Market Size Markets, 2024 & 2032
4.1.2 Smallpox Vaccine
4.1.3 Antivirals
4.1.4 Vaccinia Immune Globulin (VIG)
4.2 Segmentation by Type - Global Monkeypox Therapeutics Revenue & Forecasts
4.2.1 Segmentation by Type - Global Monkeypox Therapeutics Revenue, 2020-2025
4.2.2 Segmentation by Type - Global Monkeypox Therapeutics Revenue, 2026-2032
4.2.3 Segmentation by Type - Global Monkeypox Therapeutics Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Monkeypox Therapeutics Market Size, 2024 & 2032
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 Segmentation by Application - Global Monkeypox Therapeutics Revenue & Forecasts
5.2.1 Segmentation by Application - Global Monkeypox Therapeutics Revenue, 2020-2025
5.2.2 Segmentation by Application - Global Monkeypox Therapeutics Revenue, 2026-2032
5.2.3 Segmentation by Application - Global Monkeypox Therapeutics Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global Monkeypox Therapeutics Market Size, 2024 & 2032
6.2 By Region - Global Monkeypox Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Monkeypox Therapeutics Revenue, 2020-2025
6.2.2 By Region - Global Monkeypox Therapeutics Revenue, 2026-2032
6.2.3 By Region - Global Monkeypox Therapeutics Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America Monkeypox Therapeutics Revenue, 2020-2032
6.3.2 United States Monkeypox Therapeutics Market Size, 2020-2032
6.3.3 Canada Monkeypox Therapeutics Market Size, 2020-2032
6.3.4 Mexico Monkeypox Therapeutics Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe Monkeypox Therapeutics Revenue, 2020-2032
6.4.2 Germany Monkeypox Therapeutics Market Size, 2020-2032
6.4.3 France Monkeypox Therapeutics Market Size, 2020-2032
6.4.4 U.K. Monkeypox Therapeutics Market Size, 2020-2032
6.4.5 Italy Monkeypox Therapeutics Market Size, 2020-2032
6.4.6 Russia Monkeypox Therapeutics Market Size, 2020-2032
6.4.7 Nordic Countries Monkeypox Therapeutics Market Size, 2020-2032
6.4.8 Benelux Monkeypox Therapeutics Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia Monkeypox Therapeutics Revenue, 2020-2032
6.5.2 China Monkeypox Therapeutics Market Size, 2020-2032
6.5.3 Japan Monkeypox Therapeutics Market Size, 2020-2032
6.5.4 South Korea Monkeypox Therapeutics Market Size, 2020-2032
6.5.5 Southeast Asia Monkeypox Therapeutics Market Size, 2020-2032
6.5.6 India Monkeypox Therapeutics Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America Monkeypox Therapeutics Revenue, 2020-2032
6.6.2 Brazil Monkeypox Therapeutics Market Size, 2020-2032
6.6.3 Argentina Monkeypox Therapeutics Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Monkeypox Therapeutics Revenue, 2020-2032
6.7.2 Turkey Monkeypox Therapeutics Market Size, 2020-2032
6.7.3 Israel Monkeypox Therapeutics Market Size, 2020-2032
6.7.4 Saudi Arabia Monkeypox Therapeutics Market Size, 2020-2032
6.7.5 UAE Monkeypox Therapeutics Market Size, 2020-2032
7 Companies Profiles
7.1 Chimerix Inc.
7.1.1 Chimerix Inc. Corporate Summary
7.1.2 Chimerix Inc. Business Overview
7.1.3 Chimerix Inc. Monkeypox Therapeutics Major Product Offerings
7.1.4 Chimerix Inc. Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.1.5 Chimerix Inc. Key News & Latest Developments
7.2 SIGA Technologies, Inc.
7.2.1 SIGA Technologies, Inc. Corporate Summary
7.2.2 SIGA Technologies, Inc. Business Overview
7.2.3 SIGA Technologies, Inc. Monkeypox Therapeutics Major Product Offerings
7.2.4 SIGA Technologies, Inc. Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.2.5 SIGA Technologies, Inc. Key News & Latest Developments
7.3 Emergent BioSolutions Inc.
7.3.1 Emergent BioSolutions Inc. Corporate Summary
7.3.2 Emergent BioSolutions Inc. Business Overview
7.3.3 Emergent BioSolutions Inc. Monkeypox Therapeutics Major Product Offerings
7.3.4 Emergent BioSolutions Inc. Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.3.5 Emergent BioSolutions Inc. Key News & Latest Developments
7.4 Bavarian Nordic A/S
7.4.1 Bavarian Nordic A/S Corporate Summary
7.4.2 Bavarian Nordic A/S Business Overview
7.4.3 Bavarian Nordic A/S Monkeypox Therapeutics Major Product Offerings
7.4.4 Bavarian Nordic A/S Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.4.5 Bavarian Nordic A/S Key News & Latest Developments
7.5 Hetero Drugs Limited
7.5.1 Hetero Drugs Limited Corporate Summary
7.5.2 Hetero Drugs Limited Business Overview
7.5.3 Hetero Drugs Limited Monkeypox Therapeutics Major Product Offerings
7.5.4 Hetero Drugs Limited Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.5.5 Hetero Drugs Limited Key News & Latest Developments
7.6 Mylan N.V.
7.6.1 Mylan N.V. Corporate Summary
7.6.2 Mylan N.V. Business Overview
7.6.3 Mylan N.V. Monkeypox Therapeutics Major Product Offerings
7.6.4 Mylan N.V. Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.6.5 Mylan N.V. Key News & Latest Developments
7.7 Piramal Enterprises Limited
7.7.1 Piramal Enterprises Limited Corporate Summary
7.7.2 Piramal Enterprises Limited Business Overview
7.7.3 Piramal Enterprises Limited Monkeypox Therapeutics Major Product Offerings
7.7.4 Piramal Enterprises Limited Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.7.5 Piramal Enterprises Limited Key News & Latest Developments
7.8 Olon S.p.A.
7.8.1 Olon S.p.A. Corporate Summary
7.8.2 Olon S.p.A. Business Overview
7.8.3 Olon S.p.A. Monkeypox Therapeutics Major Product Offerings
7.8.4 Olon S.p.A. Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.8.5 Olon S.p.A. Key News & Latest Developments
7.9 Teva Pharmaceutical Industries Limited
7.9.1 Teva Pharmaceutical Industries Limited Corporate Summary
7.9.2 Teva Pharmaceutical Industries Limited Business Overview
7.9.3 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.9.5 Teva Pharmaceutical Industries Limited Key News & Latest Developments
7.10 CIDIC Company Limited
7.10.1 CIDIC Company Limited Corporate Summary
7.10.2 CIDIC Company Limited Business Overview
7.10.3 CIDIC Company Limited Monkeypox Therapeutics Major Product Offerings
7.10.4 CIDIC Company Limited Monkeypox Therapeutics Revenue in Global Market (2020-2025)
7.10.5 CIDIC Company Limited Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Monkeypox Therapeutics Market Opportunities & Trends in Global Market
Table 2. Monkeypox Therapeutics Market Drivers in Global Market
Table 3. Monkeypox Therapeutics Market Restraints in Global Market
Table 4. Key Players of Monkeypox Therapeutics in Global Market
Table 5. Top Monkeypox Therapeutics Players in Global Market, Ranking by Revenue (2024)
Table 6. Global Monkeypox Therapeutics Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global Monkeypox Therapeutics Revenue Share by Companies, 2020-2025
Table 8. Global Companies Monkeypox Therapeutics Product Type
Table 9. List of Global Tier 1 Monkeypox Therapeutics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monkeypox Therapeutics Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global Monkeypox Therapeutics Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global Monkeypox Therapeutics Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global Monkeypox Therapeutics Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global Monkeypox Therapeutics Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global Monkeypox Therapeutics Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global Monkeypox Therapeutics Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global Monkeypox Therapeutics Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America Monkeypox Therapeutics Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe Monkeypox Therapeutics Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia Monkeypox Therapeutics Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America Monkeypox Therapeutics Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa Monkeypox Therapeutics Revenue, (US$, Mn), 2026-2032
Table 30. Chimerix Inc. Corporate Summary
Table 31. Chimerix Inc. Monkeypox Therapeutics Product Offerings
Table 32. Chimerix Inc. Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 33. Chimerix Inc. Key News & Latest Developments
Table 34. SIGA Technologies, Inc. Corporate Summary
Table 35. SIGA Technologies, Inc. Monkeypox Therapeutics Product Offerings
Table 36. SIGA Technologies, Inc. Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 37. SIGA Technologies, Inc. Key News & Latest Developments
Table 38. Emergent BioSolutions Inc. Corporate Summary
Table 39. Emergent BioSolutions Inc. Monkeypox Therapeutics Product Offerings
Table 40. Emergent BioSolutions Inc. Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 41. Emergent BioSolutions Inc. Key News & Latest Developments
Table 42. Bavarian Nordic A/S Corporate Summary
Table 43. Bavarian Nordic A/S Monkeypox Therapeutics Product Offerings
Table 44. Bavarian Nordic A/S Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 45. Bavarian Nordic A/S Key News & Latest Developments
Table 46. Hetero Drugs Limited Corporate Summary
Table 47. Hetero Drugs Limited Monkeypox Therapeutics Product Offerings
Table 48. Hetero Drugs Limited Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 49. Hetero Drugs Limited Key News & Latest Developments
Table 50. Mylan N.V. Corporate Summary
Table 51. Mylan N.V. Monkeypox Therapeutics Product Offerings
Table 52. Mylan N.V. Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 53. Mylan N.V. Key News & Latest Developments
Table 54. Piramal Enterprises Limited Corporate Summary
Table 55. Piramal Enterprises Limited Monkeypox Therapeutics Product Offerings
Table 56. Piramal Enterprises Limited Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 57. Piramal Enterprises Limited Key News & Latest Developments
Table 58. Olon S.p.A. Corporate Summary
Table 59. Olon S.p.A. Monkeypox Therapeutics Product Offerings
Table 60. Olon S.p.A. Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 61. Olon S.p.A. Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Limited Corporate Summary
Table 63. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Product Offerings
Table 64. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 65. Teva Pharmaceutical Industries Limited Key News & Latest Developments
Table 66. CIDIC Company Limited Corporate Summary
Table 67. CIDIC Company Limited Monkeypox Therapeutics Product Offerings
Table 68. CIDIC Company Limited Monkeypox Therapeutics Revenue (US$, Mn) & (2020-2025)
Table 69. CIDIC Company Limited Key News & Latest Developments
List of Figures
Figure 1. Monkeypox Therapeutics Product Picture
Figure 2. Monkeypox Therapeutics Segment by Type in 2024
Figure 3. Monkeypox Therapeutics Segment by Application in 2024
Figure 4. Global Monkeypox Therapeutics Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Monkeypox Therapeutics Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Monkeypox Therapeutics Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Monkeypox Therapeutics Revenue in 2024
Figure 9. Segmentation by Type � Global Monkeypox Therapeutics Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global Monkeypox Therapeutics Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global Monkeypox Therapeutics Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global Monkeypox Therapeutics Revenue Market Share, 2020-2032
Figure 13. By Region - Global Monkeypox Therapeutics Revenue Market Share, 2020-2032
Figure 14. By Country - North America Monkeypox Therapeutics Revenue Market Share, 2020-2032
Figure 15. United States Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 16. Canada Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe Monkeypox Therapeutics Revenue Market Share, 2020-2032
Figure 19. Germany Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 20. France Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 22. Italy Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 23. Russia Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia Monkeypox Therapeutics Revenue Market Share, 2020-2032
Figure 27. China Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 28. Japan Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 31. India Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America Monkeypox Therapeutics Revenue Market Share, 2020-2032
Figure 33. Brazil Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa Monkeypox Therapeutics Revenue Market Share, 2020-2032
Figure 36. Turkey Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 37. Israel Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 39. UAE Monkeypox Therapeutics Revenue, (US$, Mn), 2020-2032
Figure 40. Chimerix Inc. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. SIGA Technologies, Inc. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Emergent BioSolutions Inc. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Bavarian Nordic A/S Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Hetero Drugs Limited Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Mylan N.V. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Piramal Enterprises Limited Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Olon S.p.A. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. CIDIC Company Limited Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
